Trials / Completed
CompletedNCT00520260
Bromfenac 0.09% vs Ketorolac 0.4% for Cyclosporine Induction Phase
Bromfenac 0.09% vs. Ketorolac 0.4% During the Induction Phase of Treatment With Topical Cyclosporine for Chronic Dry Eye Patients
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- Florida Eye Microsurgical Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To compare bromfenac 0.09% and ketorolac 0.4% when used concomitantly with cyclosporine ophthalmic emulsion 0.05% in improving patient comfort during the induction phase of treatment for chronic dry eye disease
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | bromfenac | 0.09%, BID, 6 weeks |
| DRUG | ketorolac | 0.4%, BID, 6 weeks |
Timeline
- Start date
- 2007-08-01
- Primary completion
- 2008-08-01
- Completion
- 2008-08-01
- First posted
- 2007-08-23
- Last updated
- 2009-02-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00520260. Inclusion in this directory is not an endorsement.